VB

Venkateswarlu Bhumireddy

Active Director Director DIN 11247165
DIN 11247165 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkateswarlu Bhumireddy

Data last updated:

Venkateswarlu Bhumireddy is a Director at Taro Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11247165
Primary Designation Director
Industry Pharma
First Appointment 18 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Taro Pharmaceuticals Private Limited U46497TS2025PTC202436
Director18 Aug 20252025Active

Board colleagues of Venkateswarlu Bhumireddy

NameDINCompanyDesignation
Hima Bindu Bontha11247164Taro Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Taro Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Venkateswarlu Bhumireddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkateswarlu Bhumireddy

Venkateswarlu Bhumireddy currently holds 1 directorship: Taro Pharmaceuticals Private Limited (Director, since 18 Aug 2025).

Venkateswarlu Bhumireddy was first appointed on 18 Aug 2025 as Director at Taro Pharmaceuticals Private Limited.

The current boards of Venkateswarlu Bhumireddy's companies include Hima Bindu Bontha (Taro Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available